fraction 0.63. Endomyocardial and pericardial biopsies, obtained in two patients, were normal. Follow-up (mean 22 months, range 16-42 months) revealed no cardiac deaths. These findings support the hypothesis that the restrictive hemodynamic profile does not necessarily indicate the presence of a specific pathologic process in the subendocardium or myocardium and that the prognosis is not necessarily ominous. The common pathophysiologic feature for this syndrome appears to be reduced ventricular diastolic compliance, but the etiology in many cases is unclear.
CARDIOMYOPATHIES have been divided into congestive, hypertrophic and restrictive types," 2 and a specific hemodynamic and clinical profile has been described for each class and correlated with specific etiologies.
The hemodynamic pattern of-restrictive cardiomyopathy is characterized by an elevated filling pressure in the ventricles associated with normal or nearly normal systolic function. Ventricular pressure declines significantly at the onset of diastole and then rises abruptly and rapidly in early diastole. This dipand-plateau filling pattern in the ventricular diastolic pressure tracing is manifest in the atrial pressure tracing as a prominent y descent followed by a rapid rise and plateau. The rapid rise and abrupt plateau in early diastolic ventricular pressure gives rise to the "squareroot" sign. The Patients with left-or right-heart catheterization only or those without high-quality recordings of both right and left ventricular pressures were excluded. Records of the remaining 1200 patients were reviewed and those with the following hemodynamic findings, consistent with restrictive cardiomyopathy, were selected: 1) elevation in both left ventricular end-diastolic pressure (LVEDP) and right ventricular end-diastolic pressure (RVEDP) (normal LVEDP < 12 mm Hg and RVEDP < 8 mm) not explicable by valvular, coronary, pericardial or congenital heart disease; 2) normal left ventricular systolic function (ejection fraction > 50%); and 3) characteristic early diastolic dip and subsequent rapid plateau in both ventricular pressure curves with abnormal elevation in ventricular pressure achieved with the rapid filling wave.
Patients or their physicians were contacted to assess clinical status, New York Heart Association classification and therapeutic program. The clinical presentation, noninvasive studies, catheterization data and follow-up information on patients with the diagnosis of restrictive cardiomyopathy according to the above hemodynamic criteria are the basis of this report.
Results

Clinical Characteristics
Nine of 79 patients with the diagnosis of cardiomyopathy met the criteria for diagnosis of restrictive cardiomyopathy and were selected for review. Table 1 summarizes the clinical presentation and noninvasive data. There were six males and three females. Abbreviations: NYHA = New York Heart Association; AF = atrial fibrillation; DOE = dyspnea on exertion; HSM = holosystolic murmur; NSSTTWAS = nonspecific ST-and T-wave changes; JVP = jugular venous pressure; PVR = pulmonary vascular redistribution; LVII = left ventricular hypertrophy; LAE = left atrial enlargement; SEMI = systolic ejection murmur; WNL -within normal limits; COPD = chronic obstructive pulmonary disease; ClIF = congestive heart failure; RVHI = right ventricular hypertrophy; LVE = left ventricular enlargement; RVE = right ventricular enlargement; CP = chest pain; APCs = atrial premature contractions; LLSB = lower left sternal border.
Mean age at the time of presentation was 47 years (range 23-57 years). Patients presented with a variety of complaints that were related to the cardiovascular system. These included dyspnea on exertion and fatigue (five patients), peripheral edema (three patients), angina (one patient) and atypical chest pain (three patients). In these patients, the pain was not consistently related to exertion nor a substernal location and was more a stabbing than pressure sensation. One patient presented with new atrial arrhythmias. Two patients had associated chronic obstructive lung disease and one had von Recklinghausen's syndrome. One asymptomatic patient was studied because he had a diagnosis of Noonan's syndrome, evidence of a hypertrophic cardiomyopathy, and required complete cardiovascular evaluation before he underwent general anesthesia. In summary, five patients had symptoms of dyspnea or congestive heart failure, four had chest pain and one was asymptomatic.
At the time of presentation, these patients were receiving a variety of cardiovascular medications. Five were taking digoxin and diuretics (including furosemide and spironolactone), four were taking various nitrate preparations and two were taking /3-blocking agents. Two patients were on no medications.
Physical findings were variable. One patient had an apical holosystolic murmur, one patient had a holosystolic murmur at the lower left sternal border, five patients had ejection systolic murmurs, two had third heart sounds, and one patient had a fourth heart sound. Three patients had evidence of systemic venous congestion with jugular venous distension. Three patients had peripheral edema; one of these patients also had ascites. Two patients were in atrial fibrillation, which was well controlled on digoxin therapy, and seven patients were in sinus rhythm.
Electrocardiogram
A variety of electrocardiographic findings were present that were consistent with enlargement or hypertrophy of one or more cardiac chambers. One patient had left ventricular hypertrophy with associated ST-T-wave changes consistent with digoxin therapy or a "strain" pattern. In some cases of restrictive cardiomyopathy, a specific infiltrative process such as amyloidosis can be identified. In the few cases that have been reported, the prognosis has been uniformly poor. 6 In other instances, this clinical and hemodynamic profile may be associated only with nonspecific ventricular hypertrophy and/or fibrosis.7 Can certain patients with congestive cardiomyopathy develop restrictive physiology when myocardial fibrosis becomes sufficient to reduce diastolic compliance? Our study suggests that evolution from congestive to restrictive cardiomyopathy is unlikely because all of our patients demonstrated preservation of ventricular systolic function (e.g., left ventricular ejection fraction 52-76%) at a time when there was a clear abnormality in both right and left ventricular filling pressures indicative of restrictive physiology.
In our series, patients with restrictive cardiomyopathy presented with symptoms of left and/or right ventricular failure, chest pain in the absence of significant narrowing of any epicardial coronary artery and/or symptoms from atrial arrhythmias. Physical findings were nonspecific, and evidence of systemic venous congestion was present in fewer than half the cases. Electrocardiographic findings, though nonspecific, may be compatible with restrictive myopathic process if evidence of left and/or right ventricular hypertrophy with or without a strain pattern is present. The echocardiogram is helpful in ruling out thickening or calcification within the pericardium or the presence of pericardial fluid, and may suggest a restrictive myopathic process if there is evidence of left and/or right ventricular wall thickening or asymmetric septal thickening. In no patient in our series was any pattern of abnormal ventricular diastolic wall motion suggestive of restrictive cardiomyopathy observed on the echocardiogram.
Patients with restrictive cardiomyopathy require biventricular catheterization with thorough hemodynamic evaluation to differentiate this condition from the more common causes of chest pain, congestive heart failure or arrhythmias. Coronary arteriography will establish or rule out the presence of epicardial coronary artery disease. However, a careful, more complete hemodynamic evaluation is required to identify more obscure cardiac causes of chest pain, such as pulmonary hypertension or restrictive cardiomyopathy.
A normal endomyocardial biopsy does not rule out the presence of restrictive cardiomyopathy, as illustrated by patients 3 and 6. Despite hemodynamic findings that were typical for restrictive cardiomyopathy, including similarity of right ventricular and left ventricular end-diastolic pressures in patient 3, they both had normal endomyocardial biopsies.
Thus, at times, pericardial exploration with biopsy may be required to differentiate between restrictive cardiomyopathy and constrictive pericarditis. In general, however, patients with restrictive physiology have dissimilar left and right ventricular end-diastolic pressures. Furthermore, cardiac murmurs are also uncommon in constrictive disease.
It is probable that when restrictive cardiomyopathy is associated with a specific infiltrative or fibrotic process, it carries a poor prognosis.5 However, in our series, in which no specific etiology for the restrictive hemodynamic profile could be identified, several patients noted significant symptomatic improvement over the follow-up interval. This suggests that in patients with restrictive cardiomyopathy, endomyocardial biopsy may be of prognostic importance.
We could not identify the etiologic agents and pathologic processes that resulted in the restrictive hemodynamic profile in our patients and can only speculate on the causes of this condition. In view of the somewhat reversible nature of the process, as suggested by the clinical improvement, the initial presentation and hemodynamic pattern may have resulted from myocardial edema and/or scattered inflammatory cell infiltration resulting from a subacute infectious or toxic etiology. Myocarditis has been shown experimentally to cause reduction in ventricular diastolic compliance and cause elevation in filling pressures and atrial distention.8 There may also be a subtle increase in the total cardiac volume contained within the confines of the as yet unyielding noncompliant pericardial sac. Such hemodynamic alterations may precipitate symptoms of pulmonary and systemic venous congestion, and if there is epicarditis as well, there may be atrial arrhythmias and/or chest pain. Conversely, with resolution of the subtle inflammatory changes, diastolic compliance increases, atrial distention is relieved, pericardial tension slackens and symptoms improve or resolve completely.
Possible alterations in diastolic cardiac tone or myocardial relaxation should also be considered. The similarity of hemodynamic findings in hypertrophic and restrictive cardiomyopathies are of interest in this regard. Slow-calcium-channel blockers such as verapamil have alleviated symptoms in patients with hypertrophic obstructive cardiomyopathy, presumably by reducing diastolic ventricular tone and increasing compliance.9 Such agents might be of some therapeutic benefit in patients with restrictive cardiomyopathy in whom no specific infiltrative process can be identified by histologic examination. Such a study, though important, would be difficult to perform because restrictive cardiomyopathy is infrequent, its clinical presentation nonspecific, and biventricular catheterization with careful hemodynamic evaluation is required for diagnosis. due to disease of the native valve or to the presence of an aortic prosthesis. In such cases, the response to afterload reduction therapy is uncertain because resistance at the level of the aortic valve may contribute substantially to left ventricular afterload. If this were true, drugs that lower systemic vascular resistance would be expected to have little beneficial effect on cardiac performance and might be harmful. To determine whether afterload reduction therapy is beneficial in patients with reduced aortic valve area, we evaluated the response of a group of patients with severe congestive heart failure and mild-to-moderate aortic stenosis to hydralazine9g 10, 12, 16 or prazosin,11 drugs whose predominant effect is to reduce systemic vascular resistance.
Methods Patient Population
Eleven patients with severe congestive heart failure and reduced aortic valve area were evaluated. Their clinical and hemodynamic profile is shown in table 1. There were nine males and two females whose mean age was 59 ± 3 years (SEM). Three patients had native valve stenosis and eight had an aortic valve prosthesis.
